Literature DB >> 9865113

[Efficacy and tolerance of diacerhein in the treatment of gonarthrosis and coxarthrosis].

M Lequesne1, L Berdah, I Gérentes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9865113

Source DB:  PubMed          Journal:  Rev Prat        ISSN： 0035-2640


× No keyword cloud information.
  9 in total

Review 1.  Role of interleukin-1 inhibitors in osteoarthritis: an evidence-based review.

Authors:  Zdravko Jotanovic; Radovan Mihelic; Branko Sestan; Zlatko Dembic
Journal:  Drugs Aging       Date:  2012-05-01       Impact factor: 3.923

2.  Postoperative Deep Gluteal Syndrome After Hip Arthroscopic Surgery.

Authors:  Soshi Uchida; Kazuha Kizaki; Fumitaka Hirano; Hal David Martin; Akinori Sakai
Journal:  Orthop J Sports Med       Date:  2020-09-28

3.  EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Authors:  W Zhang; M Doherty; B F Leeb; L Alekseeva; N K Arden; J W Bijlsma; F Dinçer; K Dziedzic; H J Häuselmann; G Herrero-Beaumont; P Kaklamanis; S Lohmander; E Maheu; E Martín-Mola; K Pavelka; L Punzi; S Reiter; J Sautner; J Smolen; G Verbruggen; I Zimmermann-Górska
Journal:  Ann Rheum Dis       Date:  2006-10-17       Impact factor: 19.103

4.  Attenuation of inflammatory polyarthritis in TNF transgenic mice by diacerein: comparative analysis with dexamethasone, methotrexate and anti-TNF protocols.

Authors:  Eleni Douni; Petros P Sfikakis; Sylva Haralambous; Peter Fernandes; George Kollias
Journal:  Arthritis Res Ther       Date:  2003-11-07       Impact factor: 5.156

5.  Efficacy of glucosamine plus diacerein versus monotherapy of glucosamine: a double-blind, parallel randomized clinical trial.

Authors:  Jatupon Kongtharvonskul; Patarawan Woratanarat; Mark McEvoy; John Attia; Siwadol Wongsak; Viroj Kawinwonggowit; Ammarin Thakkinstian
Journal:  Arthritis Res Ther       Date:  2016-10-12       Impact factor: 5.156

6.  Safety of Symptomatic Slow-Acting Drugs for Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis.

Authors:  Germain Honvo; Jean-Yves Reginster; Véronique Rabenda; Anton Geerinck; Ouafa Mkinsi; Alexia Charles; Rene Rizzoli; Cyrus Cooper; Bernard Avouac; Olivier Bruyère
Journal:  Drugs Aging       Date:  2019-04       Impact factor: 3.923

7.  Diacerein for the treatment of rheumatoid arthritis in patients with inadequate response to methotrexate: a pilot randomized, double-blind, placebo-controlled add-on trial.

Authors:  Worawit Louthrenoo; Surasak Nilganuwong; Ratanavadee Nanagara; Boonjing Siripaitoon; Sabine Collaud Basset
Journal:  Clin Rheumatol       Date:  2019-05-19       Impact factor: 2.980

Review 8.  Diacerein as a disease-modulating agent in osteoarthritis.

Authors:  G Falgarone; M Dougados
Journal:  Curr Rheumatol Rep       Date:  2001-12       Impact factor: 4.686

Review 9.  Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO.

Authors:  Karel Pavelka; Olivier Bruyère; Cyrus Cooper; John A Kanis; Burkhard F Leeb; Emmanuel Maheu; Johanne Martel-Pelletier; Jordi Monfort; Jean-Pierre Pelletier; René Rizzoli; Jean-Yves Reginster
Journal:  Drugs Aging       Date:  2016-02       Impact factor: 3.923
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.